| Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning DM Goldenberg, F DeLand, E Kim, S Bennett, FJ Primus, JR van Nagell Jr, ... New England Journal of Medicine 298 (25), 1384-1388, 1978 | 1066 | 1978 |
| Sacituzumab govitecan in metastatic triple-negative breast cancer A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ... New England journal of medicine 384 (16), 1529-1541, 2021 | 847 | 2021 |
| Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer A Bardia, IA Mayer, LT Vahdat, SM Tolaney, SJ Isakoff, JR Diamond, ... New England Journal of Medicine 380 (8), 741-751, 2019 | 730 | 2019 |
| Immunotherapy of B-cell malignancies using anti-CD22 antibodies DM Goldenberg US Patent 6,306,393, 2001 | 508 | 2001 |
| Targeted therapy of cancer with radiolabeled antibodies DM Goldenberg Journal of Nuclear Medicine 43 (5), 693-713, 2002 | 466 | 2002 |
| A novel method of 18F radiolabeling for PET WJ McBride, RM Sharkey, H Karacay, CA D'Souza, EA Rossi, ... Journal of nuclear medicine 50 (6), 991-998, 2009 | 451 | 2009 |
| Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy DM Goldenberg, RM Sharkey, G Paganelli, J Barbet, JF Chatal Journal of Clinical Oncology 24 (5), 816, 2006 | 399 | 2006 |
| Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen DM Goldenberg, EE Kim, FH DeLand, S Bennett, FJ Primus Cancer Research 40 (8_Part_2), 2984-2992, 1980 | 390 | 1980 |
| Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus T Dörner, J Kaufmann, WA Wegener, N Teoh, DM Goldenberg, ... Arthritis research & therapy 8, 1-11, 2006 | 377 | 2006 |
| Efficacy and safety of anti-trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer A Bardia, IA Mayer, JR Diamond, RL Moroose, SJ Isakoff, AN Starodub, ... Journal of Clinical Oncology 35 (19), 2141, 2017 | 375 | 2017 |
| Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) DM Goldenberg, TM Cardillo, SV Govindan, EA Rossi, RM Sharkey Oncotarget 6 (26), 22496, 2015 | 370 | 2015 |
| Targeted therapy of cancer: new prospects for antibodies and immunoconjugates RM Sharkey, DM Goldenberg CA: a cancer journal for clinicians 56 (4), 226-243, 2006 | 361 | 2006 |
| Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations TM Behr, DM Goldenberg, W Becker European journal of nuclear medicine 25, 201-212, 1998 | 357 | 1998 |
| Anti-CD20 antibodies and fusion proteins thereof and methods of use H Hansen, Z Qu, DM Goldenberg US Patent 7,151,164, 2006 | 341 | 2006 |
| Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections DM Goldenberg, RM Sharkey, FJ Primus Journal of the National Cancer Institute 57 (1), 11-22, 1976 | 320 | 1976 |
| Multivalent immunoglobulin-based bioactive assemblies CH Chang, DM Goldenberg, EA Rossi US Patent 7,527,787, 2009 | 317 | 2009 |
| Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study SD Steinfeld, L Tant, GR Burmester, NKW Teoh, WA Wegener, ... Arthritis research & therapy 8, 1-11, 2006 | 316 | 2006 |
| Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. DM Goldenberg, JA Horowitz, RM Sharkey, TC Hall, S Murthy, ... Journal of clinical oncology 9 (4), 548-564, 1991 | 313 | 1991 |
| Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin’s lymphoma JP Leonard, M Coleman, JC Ketas, A Chadburn, S Ely, RR Furman, ... Journal of clinical oncology 21 (16), 3051-3059, 2003 | 307 | 2003 |
| Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines C Waskewich, RD Blumenthal, H Li, R Stein, DM Goldenberg, J Burton Cancer research 62 (7), 2029-2033, 2002 | 303 | 2002 |
